DataDeposit_Impact on efficacy of target reduction of two FDA-approved ASO drugs by cellular glucose levels in in vitro cell models

This dataset are raw and processed data for the investigation of the impact of glucose level on efficacy of two FDA approved ASO drugs. Data was classified into experiment designs.

本数据集包含用于探究血糖水平对两款经美国食品药品监督管理局（Food and Drug Administration，FDA）批准的反义寡核苷酸（Antisense Oligonucleotide，ASO）药物疗效影响的原始数据与处理后数据。所有数据均依据实验设计方案完成分类。